HomeInsights
INDUSTRY:
Pharma
TOPIC:
Products & Services, Business & People, Manufacturers & Providers
TITLE:
EMA: New treatment for patients with soft tissue sarcoma
BRIEF:
The European Medicines Agency (EMA) has recommended granting a conditional marketing authorisation to Lartruvo (olaratumab) for the treatment of adults with soft tissue sarcoma, a rare type of cancer.
LEGAL IMPLICATIONS:
BUSINESS IMPLICATIONS:
